Home enteral tube feeding in patients with inherited metabolic disorders: safety issues

S Evans1, A MacDonald, A Daly

  • 1Dietetic Department, Birmingham Children's Hospital, Birmingham, UK. evanss21@onetel.com

Insights

Home enteral tube feeding (HETF) for children with inherited metabolic disorders (IMD) presents significant safety risks, including equipment failure and carer disturbance. Addressing these issues is crucial to prevent serious health complications in these vulnerable children.

Area of Science:

  • Pediatric Gastroenterology
  • Metabolic Disorders
  • Home Healthcare

Background:

  • Children with inherited metabolic disorders (IMD) often require long-term home overnight enteral tube feeding.
  • These children are at risk of hypoglycemia and metabolic decompensation.
  • Safety issues associated with home enteral tube feeding (HETF) in IMD patients have not been thoroughly evaluated.

Purpose of the Study:

  • To identify common safety concerns for children with IMD receiving HETF.
  • To assess the pressures experienced by carers managing HETF for IMD patients.

Main Methods:

  • A study involved 34 children (median age 4.1 years) with IMD on continuous overnight tube feeds.
  • Carers were interviewed using a questionnaire to gather data on.
  • Data collected included family involvement, training, child safety, equipment reliability, and carer disturbance.

Main Results:

  • 100% of carers reported sleep disturbance.
  • Common issues included tube entanglement (71%), untrained secondary carers (71%), and faulty pumps (50%).
  • Other problems were tube blockages (45%), equipment failure (32%), and child tampering (29%).

Conclusions:

  • Significant safety risks exist for children with IMD on HETF, potentially causing metabolic decompensation and hospitalization.
  • Urgent attention is needed for the safety of feeding equipment.
  • Improved training for extended family members and practical support for carers are essential.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...